Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Company news
Company news
Macrocyclic Peptidomimetics: Library Design And Synthesis
Growing interest towards medium- and large-sized macrocycles closely linked with the field of protein-protein interactions (PPI) as promising therapeutics targets.
Snap Bio and i2020 Accelerator (Torrey Pines Investment) Reach Lead Compounds Milestone for Pediatric Oncology and Advanced Liver Cancer Programs
Snap Bio, Inc.
Viriom Signed Licensing Agreement for Indonesia with P.T. Lloyd Pharma
Viriom Inc (San Diego, CA) signed a licensing agreement with P.
Meet ChemDiv at "Better Leads, Better Drugs - Innovation in Screening Libraries"
Meet ChemDiv at "Better Leads, Better Drugs - Innovation in Screening Libraries" conference held May 08-09 2019 in Boston.
Viriom China Wins Award at 2018 Zhongguancun International Frontier Science and Technology Innovation Competition
SAN DIEGO, Jan.
Torrey Pines Investment's i2020 Accelerator to Advance Snap Bio's Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases
SAN DIEGO, Nov.
Meet ChemDiv at 7th International Conference on Multicomponent Reactions and Related Chemistry
Meet ChemDiv at 7th International Conference on Multicomponent Reactions and Related Chemistry which is to be held from August 26thto 31st2018at Heinrich Heine University (Dusseldorf, Germany)...
Meet ChemDiv at EFMC-ISMC’18 International Symposium on Medicinal Chemistry
Join ChemDiv at EFMC-ISMC’18 on September 2-6, 2018 in Ljubljana, Slovenia.
ChemDiv Announces Expansion of Multi-Year Hit Identification Collaboration with Janssen
SAN DIEGO, CA (January 23, 2018) –— ChemDiv, Inc.
Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6
Regen BioPharma, Inc.
ChemDiv, DZNE and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration
SAN DIEGO and BONN, Jan.
Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS
Active Biotech (Nasdaq Stockholm.
1
2
3
4
5
6
7
8
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds
